Literature DB >> 23508959

Human cytochrome P450 1A1 structure and utility in understanding drug and xenobiotic metabolism.

Agnes A Walsh1, Grazyna D Szklarz, Emily E Scott.   

Abstract

Cytochrome P450 (CYP) 1A1 is an extrahepatic monooxygenase involved in the metabolism of endogenous substrates and drugs, as well as the activation of certain toxins and environmental pollutants. CYP1A1 is particularly well known for its ability to biotransform polycyclic aromatic hydrocarbons, such as benzo[a]pyrene in tobacco smoke, into carcinogens. CYP1A1 possesses functional similarities and differences with human CYP1A2 and CYP1B1 enzymes, but the structural basis for this has been unclear. We determined a 2.6 Å structure of human CYP1A1 with the inhibitor α-naphthoflavone. α-Naphthoflavone binds within an enclosed active site, with the planar benzochromen-4-one core packed flat against the I helix that composes one wall of the active site, and the 2-phenyl substituent oriented toward the catalytic heme iron. Comparisons with previously determined structures of the related cytochrome P450 1A2 and 1B1 enzymes reveal distinct features among the active sites that may underlie the functional variability of these enzymes. Finally, docking studies probed the ability of CYP1A structures to assist in understanding their known in vitro interactions with several typical substrates and inhibitors.

Entities:  

Keywords:  Cytochrome P450; Cytochrome P450 1A1; Docking; Drug Metabolism; Membrane Proteins; X-ray Crystallography; Xenobiotics

Mesh:

Substances:

Year:  2013        PMID: 23508959      PMCID: PMC3642336          DOI: 10.1074/jbc.M113.452953

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  65 in total

1.  Crystal structure of human cytochrome P450 2D6 with prinomastat bound.

Authors:  An Wang; Uzen Savas; Mei-Hui Hsu; C David Stout; Eric F Johnson
Journal:  J Biol Chem       Date:  2012-02-03       Impact factor: 5.157

2.  Cytochromes P4501 (CYP1): catalytic activities and inducibility by diesel exhaust particle extract and benzo[a]pyrene in intact human lung ex vivo.

Authors:  Michael M Iba; Maria Shin; Robert J Caccavale
Journal:  Toxicology       Date:  2010-05-08       Impact factor: 4.221

3.  Characterization of human lung microsomal cytochrome P-450 1A1 and its role in the oxidation of chemical carcinogens.

Authors:  T Shimada; C H Yun; H Yamazaki; J C Gautier; P H Beaune; F P Guengerich
Journal:  Mol Pharmacol       Date:  1992-05       Impact factor: 4.436

Review 4.  Cytochrome P450 activation of arylamines and heterocyclic amines.

Authors:  Donghak Kim; F Peter Guengerich
Journal:  Annu Rev Pharmacol Toxicol       Date:  2005       Impact factor: 13.820

Review 5.  Environmental and chemical carcinogenesis.

Authors:  Gerald N Wogan; Stephen S Hecht; James S Felton; Allan H Conney; Lawrence A Loeb
Journal:  Semin Cancer Biol       Date:  2004-12       Impact factor: 15.707

6.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

7.  Application of molecular modeling for prediction of substrate specificity in cytochrome P450 1A2 mutants.

Authors:  Youbin Tu; Rahul Deshmukh; Meena Sivaneri; Grazyna D Szklarz
Journal:  Drug Metab Dispos       Date:  2008-08-14       Impact factor: 3.922

8.  Induction of metabolism and transport in human intestine: validation of precision-cut slices as a tool to study induction of drug metabolism in human intestine in vitro.

Authors:  Esther G van de Kerkhof; Inge A M de Graaf; Anna-Lena B Ungell; Geny M M Groothuis
Journal:  Drug Metab Dispos       Date:  2007-12-19       Impact factor: 3.922

9.  Expression of modified human cytochrome P450 1A2 in Escherichia coli: stabilization, purification, spectral characterization, and catalytic activities of the enzyme.

Authors:  P Sandhu; Z Guo; T Baba; M V Martin; R H Tukey; F P Guengerich
Journal:  Arch Biochem Biophys       Date:  1994-02-15       Impact factor: 4.013

Review 10.  Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention.

Authors:  Vasilis P Androutsopoulos; Aristidis M Tsatsakis; Demetrios A Spandidos
Journal:  BMC Cancer       Date:  2009-06-16       Impact factor: 4.430

View more
  64 in total

Review 1.  Correlating structure and function of drug-metabolizing enzymes: progress and ongoing challenges.

Authors:  Eric F Johnson; J Patrick Connick; James R Reed; Wayne L Backes; Manoj C Desai; Lianhong Xu; D Fernando Estrada; Jennifer S Laurence; Emily E Scott
Journal:  Drug Metab Dispos       Date:  2013-10-15       Impact factor: 3.922

2.  Assessment of the effects of hepatic impairment and smoking on the pharmacokinetics of a single oral dose of the soluble guanylate cyclase stimulator riociguat (BAY 63-2521).

Authors:  Reiner Frey; Corina Becker; Sigrun Unger; Anja Schmidt; Georg Wensing; Wolfgang Mück
Journal:  Pulm Circ       Date:  2016-03       Impact factor: 3.017

3.  Predicting drug metabolism by CYP1A1, CYP1A2, and CYP1B1: insights from MetaSite, molecular docking and quantum chemical calculations.

Authors:  Preeti Pragyan; Siddharth S Kesharwani; Prajwal P Nandekar; Vijay Rathod; Abhay T Sangamwar
Journal:  Mol Divers       Date:  2014-07-16       Impact factor: 2.943

4.  Comparative proteomics among cytochrome p450 family 1 for differential substrate specificity.

Authors:  Siddharth S Kesharwani; Prajwal P Nandekar; Preeti Pragyan; Abhay T Sangamwar
Journal:  Protein J       Date:  2014-12       Impact factor: 2.371

Review 5.  Role of miRNA and its potential as a novel diagnostic biomarker in drug-induced liver injury.

Authors:  Sukumaran Sanjay; Chandrashekaran Girish
Journal:  Eur J Clin Pharmacol       Date:  2016-12-27       Impact factor: 2.953

Review 6.  Molecular changes in hepatic metabolism and transport in cirrhosis and their functional importance.

Authors:  Christoph G Dietrich; Oliver Götze; Andreas Geier
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

7.  Cigarette smoke induces proteasomal-mediated degradation of DNA methyltransferases and methyl CpG-/CpG domain-binding proteins in embryonic orofacial cells.

Authors:  Partha Mukhopadhyay; Robert M Greene; M Michele Pisano
Journal:  Reprod Toxicol       Date:  2015-10-22       Impact factor: 3.143

8.  Effects of insulin treatment on hepatic CYP1A1 and CYP2E1 activities and lipid peroxidation levels in streptozotocin-induced diabetic rats.

Authors:  Gökçe Kuzgun; Rahman Başaran; Ebru Arıoğlu İnan; Benay Can Eke
Journal:  J Diabetes Metab Disord       Date:  2020-08-24

Review 9.  Polycyclic aromatic hydrocarbons: from metabolism to lung cancer.

Authors:  Bhagavatula Moorthy; Chun Chu; Danielle J Carlin
Journal:  Toxicol Sci       Date:  2015-05       Impact factor: 4.849

10.  A Ligand-Based Drug Design. Discovery of 4-Trifluoromethyl-7,8-pyranocoumarin as a Selective Inhibitor of Human Cytochrome P450 1A2.

Authors:  Jiawang Liu; Peter T Pham; Elena V Skripnikova; Shilong Zheng; La'nese J Lovings; Yuji Wang; Navneet Goyal; Sydni M Bellow; Lydia M Mensah; Amari J Chatters; Melyssa R Bratton; Thomas E Wiese; Ming Zhao; Guangdi Wang; Maryam Foroozesh
Journal:  J Med Chem       Date:  2015-08-10       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.